Hologic Inks Deal to Acquire Gen-Probe for $3.7B | GenomeWeb

NEW YORK (GenomeWeb News) – Hologic announced prior to market opening today that it will acquire Gen-Probe for approximately $3.7 billion, creating what company officials called the largest diagnostics company focused on women's health.

Terms of the all-cash transaction call for Hologic to acquire all outstanding shares of Gen-Probe for $82.75 per share, funded through available cash and additional financing.

Hologic said that it expects the deal to close in the second half of 2012, subject to approval by GenProbe's shareholders and other customary closing conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.